Reconsidering fibrinolysis in selected patients with non–ST-elevation acute coronary syndrome: A hypothesis-generating, research-based framework

Authors' conclusion

This article does not propose a change in clinical practice. Instead, it outlines a hypothesis-generating, research-based framework to explore whether, in highly selected circumstances and in the absence of timely PCI, fibrinolytic therapy could be studied in NSTE-ACS patients with probable acute coronary occlusion identified by advanced diagnostic tools.